FWP
FAS Wealth Partners’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
149,160
+9,625
| +7% | +$168K | 0.19% | 103 |
|
|
2025
Q1 | $1.76M | Buy |
139,535
+44,830
| +47% | +$564K | 0.14% | 119 |
|
|
2024
Q4 | $999K | Buy |
94,705
+9,850
| +12% | +$104K | 0.08% | 147 |
|
|
2024
Q3 | $1.23M | Buy |
84,855
+17,199
| +25% | +$249K | 0.1% | 136 |
|
|
2024
Q2 | $576K | Buy |
67,656
+7,186
| +12% | +$61.2K | 0.05% | 187 |
|
|
2024
Q1 | $618K | Buy |
60,470
+14,500
| +32% | +$148K | 0.05% | 180 |
|
|
2023
Q4 | $252K | Hold |
45,970
| – | – | 0.02% | 265 |
|
|
2023
Q3 | $174K | Buy |
45,970
+11,720
| +34% | +$44.3K | 0.02% | 279 |
|
|
2023
Q2 | $229K | Buy |
+34,250
| New | +$229K | 0.03% | 242 |
|